WINDTREE THERAPEUTICS INC /DE/ Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2023-03-31
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-06-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $2.14M, a 759.84% increase from fiscal 2020.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $249.00K, a 31.59% decline from fiscal 2019.
- WINDTREE THERAPEUTICS INC /DE/ right-of-use asset obtained in exchange for operating lease liability for fiscal 2019 was $364.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $141.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $141.00K derived: sum of 3 quarters · filed 2023-03-31 | $141.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $141.00K derived: sum of 2 quarters · filed 2023-03-31 | $141.00K derived: sum of 3 quarters · filed 2023-03-31 | $141.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $141.00K derived: sum of 2 quarters · filed 2023-03-31 | $141.00K derived: sum of 3 quarters · filed 2023-03-31 | $2.14M 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $2.00M 10-Q · filed 2022-11-14 | $2.25M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.00M 10-Q · filed 2022-08-11 | $2.25M derived: sum of 3 quarters · filed 2022-08-11 | $2.25M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-05 | $2.25M derived: sum of 2 quarters · filed 2022-05-05 | $2.25M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $249.00K derived: sum of 2 quarters · filed 2022-03-31 | $249.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $232.00K derived: sum of 2 quarters · filed 2021-03-29 | $364.00K derived: sum of 3 quarters · filed 2021-03-29 | $364.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $232.00K 10-Q · filed 2019-11-14 | $364.00K derived: sum of 2 quarters · filed 2019-11-14 | $364.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $132.00K 10-Q · filed 2019-08-14 | $132.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |